Consumer Preferences for Types of Cost Containment in Prescription Drug Programs
2002; Academy of Managed Care Pharmacy; Volume: 8; Issue: 3 Linguagem: Inglês
10.18553/jmcp.2002.8.3.192
ISSN1944-706X
Autores Tópico(s)Patient Satisfaction in Healthcare
ResumoOBJECTIVE: To estimate (1) the relative importance of three major attributes of prescription drug benefit plans level of copayment, pharmacy access, and access to products that health plans use to control prescription drug expenditures and (2) the trade-offs that consumers make among these attributes. DESIGN: Self-administered survey and conjoint analysis of consumer preference data. PARTICIPANTS: A convenience sample of 130 consumers in Richmond, Va. MAIN OUTCOME MEASURES: Consumer preference ratings for 11 hypothetical drug benefit plans; relative importance consumers attributed to level of copayment, pharmacy access, and access to products in selecting drug benefit plans; trade-offs consumers made among these attributes. RESULTS: Product choice was the most important attribute in selecting a drug benefit plan. The importance rating was 42.1%. Consumers indicated strong preferences for open formularies. Level of copay received an importance rating of 31.9%. Higher copays were associated with lower consumer preference. Choice of pharmacy had an importance value of 26.0%. Consumers preferred plans that allowed either free choice of pharmacy or that included their current pharmacy. A market segmentation analysis yielded similar results. CONCLUSIONS: Conjoint analysis provides useful consumer preference and trade-off information that health plans could use to minimize consumer dissatisfaction with drug benefit plans.
Referência(s)